Synthesis of a New Dual Metalloprotease Inhibitor. II. Stereoselective Synthesis of Peptidomimetic [5.7]-Bicyclic Compounds

An efficient synthetic process for the key intermediate of a new peptidomimetic dual metalloprotease inhibitor, ER-40133, was developed. (5R)-Methyl-6-oxopipecolic acid ester (3a), prepared from L-α-aminoadipic acid, was chemoselectively reduced to the protected (5R)-methyl-6-hydroxypipecolic acid e...

Full description

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 47; no. 11; pp. 1532 - 1537
Main Authors AKASAKA, Kozo, KOMATSU, Yuki, TAGAMI, Katsuya, SHIMIZU, Toshikazu, SHIMOMURA, Naoyuki, NAKA, Hiroshi, HAYASHI, Kenji, NEGI, Shigeto
Format Journal Article
LanguageEnglish
Published TOKYO The Pharmaceutical Society of Japan 1999
Pharmaceutical Soc Japan
Maruzen
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An efficient synthetic process for the key intermediate of a new peptidomimetic dual metalloprotease inhibitor, ER-40133, was developed. (5R)-Methyl-6-oxopipecolic acid ester (3a), prepared from L-α-aminoadipic acid, was chemoselectively reduced to the protected (5R)-methyl-6-hydroxypipecolic acid ester (4a), followed by treatment with L-cysteine methyl ester to give the linear key intermediate (5a) with the desired configuration. After deprotection of the ester moiety of 5a, the newly generated carboxylic acid group was intramolecularly condensed with the amino group at the thiazolidine ring using ethyl chloroformate in the presence of base to provide [5.7]-bicyclic compound (7a) with the desired configuration in excellent yield. Lastly, the methyl ester of 7a was hydrolyzed under alkaline conditions to afford 8a, a key intermediate for ER-40133.
ISSN:0009-2363
1347-5223
DOI:10.1248/cpb.47.1532